Literature DB >> 20639195

Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states.

Parvathi Kamath1, James A Huntington, Sriram Krishnaswamy.   

Abstract

The critical and multiple roles of thrombin in blood coagulation are regulated by ligands and cofactors. Zymogen activation imparts proteolytic activity to thrombin and also affects the binding of ligands to its two principal exosites. We have used the activation peptide fragment 1.2 (F12), a ligand for anion-binding exosite 2, to probe the zymogenicity of thrombin by isothermal titration calorimetry. We show that F12 binding is sensitive to subtle aspects of proteinase formation beyond simply reporting on zymogen cleavage. Large thermodynamic differences in F12 binding distinguish between a series of thrombin species poised along the transition of zymogen to proteinase. Active-site ligands transitioned a zymogen-like state to a proteinase-like state. Conversely, removal of Na(+) converted proteinase-like thrombin to a more zymogen-like form. Thrombin mutants, with deformed x-ray structures, previously considered to be emblematic of specific regulated states of the enzyme, are instead shown to be variously zymogen-like and can be made proteinase-like by active-site ligation. Thermodynamic linkage between anion-binding exosite 2, the Na(+)-binding site, and the active site arises from interconversions of thrombin between a continuum of zymogen- and proteinase-like states. These interconversions, reciprocally regulated by different ligands, cast new light on the problem of thrombin allostery and provide a thermodynamic framework to explain the regulation of thrombin by different ligands.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639195      PMCID: PMC2937891          DOI: 10.1074/jbc.M110.154914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.

Authors:  Ingrid M Verhamme; Steven T Olson; Douglas M Tollefsen; Paul E Bock
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

2.  Molecular dissection of Na+ binding to thrombin.

Authors:  Agustin O Pineda; Christopher J Carrell; Leslie A Bush; Swati Prasad; Sonia Caccia; Zhi-Wei Chen; F Scott Mathews; Enrico Di Cera
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

3.  Thrombin.

Authors:  R L Lundblad; H S Kingdon; K G Mann
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

4.  Equilibrium and rate constants for the interconversion of two conformations of -chymotrypsin. The existence of a catalytically inactive conformation at neutral p H.

Authors:  A R Fersht; Y Requena
Journal:  J Mol Biol       Date:  1971-09-14       Impact factor: 5.469

Review 5.  Prothrombin.

Authors:  K G Mann; J Elion; R J Butkowski; M Downing; M E Nesheim
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Authors:  M E Nesheim; F G Prendergast; K G Mann
Journal:  Biochemistry       Date:  1979-03-20       Impact factor: 3.162

7.  Entropy-enthalpy compensation: fact or artifact?

Authors:  K Sharp
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

Review 8.  Thrombin formation.

Authors:  Kenneth G Mann
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

9.  The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket.

Authors:  Agustin O Pineda; Zhi-Wei Chen; Sonia Caccia; Angelene M Cantwell; Savvas N Savvides; Gabriel Waksman; F Scott Mathews; Enrico Di Cera
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

10.  Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery.

Authors:  Wendy J Carter; Timothy Myles; Craig S Gibbs; Lawrence L Leung; James A Huntington
Journal:  J Biol Chem       Date:  2004-04-09       Impact factor: 5.157

View more
  30 in total

Review 1.  Conformational selection in trypsin-like proteases.

Authors:  Nicola Pozzi; Austin D Vogt; David W Gohara; Enrico Di Cera
Journal:  Curr Opin Struct Biol       Date:  2012-06-03       Impact factor: 6.809

2.  Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold.

Authors:  Austin D Vogt; Pradipta Chakraborty; Enrico Di Cera
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

3.  Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein.

Authors:  Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

4.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

5.  Interaction of thrombin with sucrose octasulfate.

Authors:  Bijoy J Desai; Rio S Boothello; Akul Y Mehta; J Neel Scarsdale; H Tonie Wright; Umesh R Desai
Journal:  Biochemistry       Date:  2011-07-18       Impact factor: 3.162

Review 6.  The transition of prothrombin to thrombin.

Authors:  S Krishnaswamy
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

7.  Meizothrombin is an unexpectedly zymogen-like variant of thrombin.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

Review 8.  Essential role of conformational selection in ligand binding.

Authors:  Austin D Vogt; Nicola Pozzi; Zhiwei Chen; Enrico Di Cera
Journal:  Biophys Chem       Date:  2013-09-25       Impact factor: 2.352

9.  Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.

Authors:  Amal Arachiche; Michele M Mumaw; María de la Fuente; Marvin T Nieman
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

10.  Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.

Authors:  Preetpal Singh Sidhu; May H Abdel Aziz; Aurijit Sarkar; Akul Y Mehta; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2013-06-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.